NCT06819774招募中3 期
Efficacy and Safety of Cetirizine Hydrochloride Injection in the Treatment of Acute Urticaria: a Randomized, Double-blind, Positive Controlled, Multicenter Phase III Clinical Study
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 284
- 试验地点
- 1
- 主要终点
- Scoring of the severity of pruritus
研究概览
简要总结
The objective of this study was to evaluate the efficacy and safety of cetirizine hydrochloride injection in the treatment of acute urticaria.The participants were randomized to receive cetirizine hydrochloride or diphenhydramine hydrochloride.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age range: 18 - 65 years old (inclusive of the threshold value), gender not limited;
- •Diagnosed with acute urticaria (the definition of acute urticaria: spontaneous wheals and/or angioedema attacks ≤ 6 weeks);
- •At screening，the severity score of pruritus of the patient was ≥ 1 point ;
- •At screening，the degree score of wheals/erythema of the patient assessed by the investigator was ≥ 1 point ;
- •Be willing and able to give informed consent.
排除标准
- •Patients in whom an antihistamine are contraindicated (such as those with angle-closure glaucoma, symptomatic benign prostatic hyperplasia, etc.);
- •Patients who used H1 antagonists (such as diphenhydramine, cetirizine, loratadine, fexofenadine, levocetirizine, desloratadine, etc.) within 2 hours before randomization;
- •Patients who used H2 antagonists (such as cimetidine, ranitidine, famotidine, roxatidine, etc.) within 2 hours before randomization;
- •Patients who used doxepin within 2 hours before randomization;
- •Patients who received steroid hormone treatment for acute allergic reactions within 4 hours before randomization;
- •Patients who used epinephrine within 20 minutes before randomization;
- •Patients who are known to be allergic to hydroxyzine, cetirizine, levocetirizine, diphenhydramine;
- •Pregnant or lactating women; or those who have a pregnancy plan or plan to donate sperm/eggs from the screening day to the end of medication within 1 month; or those who are unwilling to take one or more contraceptive measures from the screening day to the end of medication within 1 month;
- •Patients with urticarial drug eruption;
- •Patients with acute urticaria who have concurrent symptoms such as laryngeal edema, allergic asthma, anaphylactic shock during screening;
- •Patients with urticarial vasculitis, hereditary angioedema, antihistamine-resistant urticaria or skin diseases that interfere with the evaluation of treatment efficacy during screening;
- •Patients with a history of immunodeficiency;
- •Patients with other major medical conditions (such as blood diseases, cardiovascular and cerebrovascular diseases, liver diseases, kidney diseases, etc.) or mental disorders and judged by the investigator to be unsuitable to participate in this study;
- •Patients who are concurrently using P-glycoprotein inhibitors (such as cyclosporine, itraconazole, dronedarone, amiodarone, quinidine, verapamil, etc.) during screening;
- •Patients who participated in other clinical trials within 3 months before screening (excluding those who only participated in the screening of the clinical trial but did not use the trial drugs or devices);
- •Patients with acute urticaria accompanied by fever during screening;
- •Patients engaged in dangerous jobs such as driving, high-altitude work, mechanical operation, etc., and cannot stop within 48 hours after medication;
- •Other various situations.
研究组 & 干预措施
Arm 1
Experimental
Cetirizine hydrochloride injection；diphenhydramine hydrochloride injection simulator
干预措施: Cetirizine Hydrochloride Injection (Drug)
Arm 2
Experimental
diphenhydramine hydrochloride injection ；Cetirizine hydrochloride injection simulant
干预措施: Diphenhydramine Hydrochloride Injection (Drug)
结局指标
主要结局
Scoring of the severity of pruritus
时间窗: Two hours after the treatment was completed
Scoring of the severity of pruritus
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)SARRhinitis, Allergic, SeasonalAllergic RhinitisHay FeverNCT02932774Johnson & Johnson Consumer and Personal Products Worldwide683
已完成
3 期
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown OriginChronic UrticariaAllergic RhinitisNCT00619801UCB Pharma173
已完成
2 期
Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic RhinitisSeasonal Allergic RhinitisNCT01651871Shionogi779
已完成
4 期
Comparison of two drugs cetrizine and bilastine in patients of urticariaCTRI/2020/05/025031Dr Vishakha Sinha63
已完成
不适用
Effect of cetrizine on functional dyspepsiaFunctional Dyspepsia.functional disorders of stomachIRCT2012121211738N1Tabriz University of Medical Sciences30